1. Home
  2. MBBC vs CPHI Comparison

MBBC vs CPHI Comparison

Compare MBBC & CPHI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Marathon Bancorp Inc.

MBBC

Marathon Bancorp Inc.

N/A

Current Price

$15.23

Market Cap

44.1M

Sector

Finance

ML Signal

N/A

Logo China Pharma Holdings Inc.

CPHI

China Pharma Holdings Inc.

N/A

Current Price

$0.90

Market Cap

46.5M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
MBBC
CPHI
Founded
1902
N/A
Country
United States
China
Employees
N/A
N/A
Industry
Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
44.1M
46.5M
IPO Year
2020
2008

Fundamental Metrics

Financial Performance
Metric
MBBC
CPHI
Price
$15.23
$0.90
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
2.0K
495.9K
Earning Date
05-12-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
122.22
N/A
EPS
0.53
N/A
Revenue
N/A
$4,144,268.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$29.06
N/A
Revenue Growth
N/A
N/A
52 Week Low
$10.25
$0.38
52 Week High
$15.79
$19.19

Technical Indicators

Market Signals
Indicator
MBBC
CPHI
Relative Strength Index (RSI) 57.44 45.97
Support Level $14.63 $0.53
Resistance Level $15.77 $1.43
Average True Range (ATR) 0.12 0.08
MACD 0.03 -0.03
Stochastic Oscillator 93.94 11.65

Price Performance

Historical Comparison
MBBC
CPHI

About MBBC Marathon Bancorp Inc.

Marathon Bancorp Inc is a mid-tier holding company for Marathon Bank, a Wisconsin-chartered savings bank. The group operates as a community-oriented bank offering a variety of financial products and services to meet the needs of customers. The primary deposit products are demand deposits, savings, and certificates of deposits; and prime lending products are commercial real estate, commercial and industrial, construction, one-to-four-family residential, multifamily real estate, and consumer loans. The majority of the group's revenue comes from interest income on loans and debt securities.

About CPHI China Pharma Holdings Inc.

China Pharma Holding Inc is a drug manufacturing company. It is mainly engaged in the development, manufacture, and marketing of pharmaceutical products for human use in connection with a variety of high-incidence and high-mortality diseases and medical conditions prevalent in the People's Republic of China. The company mainly manufactures pharmaceutical products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions. The product line of the company includes cefaclor dispersible tablets, clarithromycin granules, roxithromycin dispersible tablets, andrographolide tablets, ozagrel sodium for injection, gastrodin injection, and others.

Share on Social Networks: